Senaste uppdateringen :
19/11/2024
Antibiotikum   Temocilline  
injektion
Lösningars stabilitet Stabilitet i blandningar Faktorer som påverkar stabiliteten Kompatibilitet Administreringssätt Hänvisningar pdf
   Molekylstruktur  

Varunamn   Varunamn     

Angivna handelsnamn på läkemedel är enbart vägledande då formulering inklusive hjälpämnen kan variera mellan länder och tillverkare

Negaban Belgien, Frankrike, Luxemburg, Storbritannien
Hänvisningar   injektion   Hänvisningar : Temocilline  
Typ Publikation
2231 tidningen de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S.
Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection.
J Antimicrob Chemother 2008 ; 61, 2: 382-388.
2275 tidningen Craig Dyar S, Notari RE.
Hydrolysis kinetics and stability predictions for a mixture of R and S temocillin isomers.
Int J Pharm 1998 ; 173: 221-232.
2296 Laboratorium Témocilline (Negaban®) - Résumé des caractéristiques du produit
Eumedica 2017
3154 tidningen Carryn S, Couwenbergh N, Tulkens PM
Long-term stability of temocillin in elastomeric pumps for outpatient antibiotic therapy in cystic fibrosis patients.
J Antimicrob Chemother 2010 ; 65, 9: 2045-2046.
3255 tidningen Rolin C, Hecq J.D, Tulkens P, Vanbeckbergen D, Jamart J, LGalanti L.
Long-term stability of temocillin in dextrose 5% and in sodium chloride 0.9% polyolefin bags at 5±3°C after freeze-thaw treatment
Ann Pharm Fr 2011 ; 69, 6 : 296-301.
3385 tidningen Raverdi V, Ampe E, Hecq JD, Tulkens PM.
Stability and compatibility of vancomycin for administration by continuous infusion.
J Antimicrob Chemother 2013 ; 68: 1179-1182.
3520 Laboratorium Cidomycin - Summary of product Chracteristics.
Sanofi 2011
3529 Laboratorium Ciprofloxacin – Summary of Product Characteristics
Hospira 2013
3549 Laboratorium Amikacine B Braun - Résumé des caractéristiques du produit.
B Braun 2012
3643 Laboratorium Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics
Sanofi 2015
3674 Laboratorium Erythromycin lactobionate - Summary of Product Characteristics
PanPharma 2016
4470 tidningen Claeysoone K, Basma V, Hens R, Van Bambeke F, de Jongh R, Tulkens P.
Continuous versus intermittent infusion of temocillin in intensive care unit patient.
Critical care 2005 ; 9(Suppl 1) P37
4634 tidningen Loeuille G, D'Huart E, Vigneron J, Nisse YE, Beiler B, Polo C, Ayari G, Sacrez M, Demoré B, Charmillon A.
Stability studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy.
Antibiotics 2022 ;11,4: 458

  Mentions Légales